Estradiol - MIGENIX

Drug Profile

Estradiol - MIGENIX

Alternative Names: CardioStat; MITO-0139; NeuroStat

Latest Information Update: 15 Jun 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MIGENIX
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Stroke

Most Recent Events

  • 15 Jun 2007 Discontinued - Preclinical for Stroke in USA (SC)
  • 21 Sep 2004 Micrologix Biotech is now called MIGENIX
  • 15 Oct 2002 This agent is still in active development
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top